Actively Recruiting
IVUS CHIP China Registry
Led by Shanghai Zhongshan Hospital · Updated on 2024-04-26
2020
Participants Needed
1
Research Sites
203 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to learn about in patients with complex coronary lesions undergoing PCI. The main question\[s\] it aims to answer are: the clinical efficacy and safety of an IVUS-guided approach in patients with complex coronary lesions undergoing PCI, as well as clinical outcomes up to 2 years. Participants will be treated with IVUS-guided PCI.
CONDITIONS
Official Title
IVUS CHIP China Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient is 18 years of age or older
- Has indication for PCI for at least one lesion meeting any of the following: angiographic heavy calcification, ostial lesions, true bifurcation lesions involving side branches larger than 2.5mm, left main lesions, chronic total occlusion, in-stent restenosis, or long lesions (stent length over 28mm) or needs elective mechanical circulatory support assisted PCI
- Presents with silent ischemia, stable angina, unstable angina, or non-ST-elevation acute coronary syndrome
- All lesions are suitable for treatment with second-generation drug-eluting stents or drug-coated balloons when indicated
- Willing and able to cooperate with registry procedures and follow-up until study completion
- Able to understand risks, benefits, and treatment alternatives and provides informed consent prior to any protocol procedure
You will not qualify if you...
- ST-elevation myocardial infarction or cardiogenic shock within the prior 7 days
- Known untreated severe valvular heart disease
- Requires PCI in a diseased aorto-coronary bypass
- Known contraindication or hypersensitivity to anticoagulants
- Absolute contraindications or allergies that cannot be pre-medicated to iodinated contrast or antiplatelet drugs including aspirin and P2Y12 inhibitors
- Non-cardiac medical conditions with life expectancy less than 1 year
- Currently participating in another clinical trial that has not reached its primary endpoint
- Women who are pregnant or breastfeeding
- Circumstances preventing appropriate consenting or follow-up as determined by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fudan Zhongshan Hospital
Shanghai, China
Actively Recruiting
Research Team
C
Chenguang Li, Doctor
CONTACT
J
Junbo Ge, Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here